No Associations Between Regular Use of Proton Pump Inhibitors and Risk of All-Cause and Cause-Specific Mortality: A Population-Based Cohort of 0.44 Million Participants

Qiangsheng He, Bin Xia, Wenbo Meng, Die Fan, Zi Chong Kuo, Junjie Huang, Xiwen Qin, Huachun Zou, Yulong He, Changhua Zhang, Shuo Fang, Yihang Pan, Man Yang, Jinqiu Yuan

Research output: Contribution to journalArticlepeer-review

14 Citations (Web of Science)

Abstract

INTRODUCTION: The association between proton pump inhibitors' (PPIs) use and mortality remains unclear. METHODS: This was a prospective analysis of 440,840 UK residents and 13,154 deaths. We evaluated the associations with multivariate Cox regression. RESULTS: After adjusting for confounders, such as over health status and longstanding diseases, the regular use of PPIs was not associated with an increased risk of all-cause mortality and mortality due to neoplasms, circulatory system diseases, respiratory system diseases, digestive system diseases, external causes, and other causes. DISCUSSION: Regular use of PPIs was not associated with an increased risk of all-cause and cause-specific mortality.

Original languageEnglish
Pages (from-to)2286-2291
Number of pages6
JournalThe American Journal of Gastroenterology
Volume116
Issue number11
DOIs
Publication statusPublished - 1 Nov 2021

Fingerprint

Dive into the research topics of 'No Associations Between Regular Use of Proton Pump Inhibitors and Risk of All-Cause and Cause-Specific Mortality: A Population-Based Cohort of 0.44 Million Participants'. Together they form a unique fingerprint.

Cite this